ARCI Releases One-Year Analysis Of HISA Programs

A staff report from the Association of Racing Commissioners International (ARCI) was issued Friday providing data and a programmatic analysis of HISA Programs  after its first year responsible for equine and racetrack safety in Thoroughbred racing and six months responsibility for anti-doping and medication control. 

The main takeaways are: 

  • HISA's biggest success lies in common rules and drug testing; 
  • HISA/HIWU Testing Labs have not found any new drugs that had not been found under the previous state based programs; 
  • Based on HIWU statements as to the extent of testing and HIWU website postings, it appears the rate of adverse analytical findings triggering regulatory review or action is roughly the same as the previous state-based program.
  • The equine fatality rate remains small and results are mixed as to whether HISA has had any effect, either way.  
  • HISA receives considerable help from State Racing Commissions who are expected to provide almost $18 million in funding or services in the coming  year. 
  • HISA's almost $81 million proposed budget for next year relies on the Thoroughbred racing industry paying almost $60 million in assessments. 

The report was prepared for State Racing Commissions who anticipate being asked by state legislative oversight committees as to the performance of HISA in their State. It is considered preliminary and is the first and only independent assessment of the new program so far. To date there has been no congressional oversight or review by the Federal Trade Commission. 

The full report is available here: HISA Assessment and Analysis

The post ARCI Releases One-Year Analysis Of HISA Programs appeared first on Horse Racing News | Paulick Report.

Source of original post

Making Waves: Es Equ Love Gelding Shines In Arcadia

   In this series, the TDN takes a look at notable successes of European-based sires in North America. This week's column is highlighted by the victory of Hong Kong Harry at Santa Anita last week.

 

Hong Kong Harry Returns A Winner In City Of Hope

Prolific graded winner Hong Kong Harry (Ire) (Es Que Love {Ire}) returned to winning ways in Santa Anita's GII City of Hope Mile S. for trainer Phil D'Amato and owners Scott Anastasi, Jimmy Ukegawa and Tony Valazza at the end of September (video). It was his fourth win at the graded level since being transferred to the U.S. in March of 2022.

Bred by Amarath Business Management out of the multiple stakes-placed Vital Body (Fr) (Gold Away {Ire}), the 6-year-old gelding won multiple handicaps in the UK, and was a £185,000 Goffs London Sale buy-back during his time with owner/trainer Richard Fahey in 2021. When he was reoffered by the trainer later that year at the 2021 Tattersalls Autumn Horses-in-Training Sale, he made 85,000gns from Craig Rounsefell's Boomer Bloodstock. Vital Body has also thrown the stakes-placed Body Sculpt (Fr) to the cover of Kendargent (Fr) and her latest is a weanling filly by Starman (GB). This is the same clan as G2 Prix du Gros-Chene hero Pradaro (Fr) (Penny's Picnic {Ire}) and Australian Group 1 winner Offer (Ire) (Montjeu {Ire}).

One of just 80 foals for his sire who was last reported to be standing in France, Hong Kong Harry is his only graded winner and one of two stakes winners besides listed winner Que Amoro (Ire). Es Que Love has two winners from two runners in the U.S.

 

 

Gavea Remains Undefeated At Churchill

Bal Mar Equine, LLC's Gavea (Ger) (Gleneagles {Ire}), a debut winner at Chantilly for Christoph Berglar and trainer Waldemar Hickst in July, marked her U.S. unveiling with another victory, this time at Churchill Downs on Sept. 29 (video).

Now trained by Al Stall, Jr., the 2-year-old filly was bred by Stiftung Gestut Fahrhof and was bought back by her vendor for €36,000 out of the BBAG September Yearling Sale after not meeting her reserve. She is a half-sister to a pair of winners and is the last reported foal of her German listed-winning dam, the Oasis Dream (GB) mare Goiania (GB). Goiania is a half-sister to two stakes winners, the trio all produced by German Group 3 heroine Goathemala (Ger) (Black Sam Bellamy {Ire}).

Gleneagles is quietly accumulating a solid stallion resume with his progeny worldwide, and he is responsible for 13 winners from 19 runners (68%) in the U.S. His American brigade is led by GI Man o'War S. hero Highland Chief (Ire), while Jumbly (GB) was third in the GII Ballston Spa S. and Eylara (Ire) was listed placed in California.

 

 

 

Gold To The North East In California

CYBT, Marc Lantzman, Michael Nentwig and Ray Pagano's North East Star (Ire) (Galileo Gold {GB}) graduated in her fifth start at Santa Anita on Sept. 30 (video). One of two European-sired winners on the card for trainer Phil D'Amato, the filly was bred by McCracken Farms.

A £17,000 Tattersalls Ireland yearling buy by subsequent owner/trainer Kate McGivern, the April foal is out of Northeast Moon (Ire) (Sea The Moon {Ger}), herself a half-sister to G1 Dubai World Cup hero Prince Bishop (Ire) (Dubawi {Ire}). Her only European appearance was a fifth at Dundalk over the all-weather before she changed hands. Her dam's 2-year-old filly, Circe (Ire) (Kodiac {GB}) has already won this term, while her yearling filly by Ghaiyyath (Ire) caught the eye of Alex Elliott for 140,000gns during Book 1 of the Tattersalls October Yearling Sale. A weanling filly by Sottsass (Fr) is her latest foal.

Group 1 sire Galileo Gold has a 75% strike rate with his four American runners. Among his three winners in that jurisdiction is Listed Baffle S. winner Maglev (Ire).

 

 

The post Making Waves: Es Equ Love Gelding Shines In Arcadia appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Kentucky Oaks Winner Secret Oath Retired, To Sell At Fasig-Tipton November

Secret Oath, the winner of the 2022 Kentucky Oaks, has been retired from racing due to a minor ankle injury, and she will be offered at next month's Fasig-Tipton November Sale, BloodHorse reports.

The 4-year-old daughter of Arrogate finished her career with six wins in 18 starts, earning $2,444,767 as a homebred for Briland Farm. She was trained by D. Wayne Lukas.

Secret Oath established herself as a top Kentucky Oaks contender during the spring season at Oaklawn Park, where she took the listed Martha Washington Stakes and the Grade 3 Honeybee Stakes. After testing male competition in the G1 Arkansas Derby and finishing third, Secret Oath took command in the stretch of the Kentucky Oaks and drew away to win by two lengths.

She kicked off her 2023 campaign with a victory in the G2 Azeri Stakes, then she finished second in three of her next four starts, most recently turning in a runner-up effort in the G1 Personal Ensign Stakes at Saratoga on Aug. 25. The filly was being pointed toward the G1 Spinster Stakes on Oct. 8 at Keeneland before sustaining her injury.

Secret Oath will be offered at the Fasig-Tipton November Sale on Tuesday, Nov. 7 as Hip 180, consigned by Bluewater Sales, agent.

Read more at BloodHorse.

The post Kentucky Oaks Winner Secret Oath Retired, To Sell At Fasig-Tipton November appeared first on Horse Racing News | Paulick Report.

Source of original post

ARCI Questions HISA’s Effectiveness in New Report; HISA Claims Report `Factually Inaccurate’

A staff report from the Association of Racing Commissioners International (ARCI) was issued today providing “data and a programmatic analysis HISA Programs after its first year,” with the conclusion that HISA has done little to deter the doping of racehorses or effect the catastrophic breakdown rate, according to a press release from the ARCI. HISA responded to the report, saying it was “riddled with factual inaccuracies and mischaracterizations.”

ARCI claims that after one year of being responsible for equine and racetrack safety in thoroughbred racing and six months responsibility for anti-doping and medication control, that HISA's “biggest success lies in common rules and drug testing.” Moreover, they claim, “HISA/HIWU Testing Labs have not found any new drugs that had not been found under the previous state based programs,” and “based on HIWU statements as to the extent of testing and HIWU website postings, it appears the rate of adverse analytical findings triggering regulatory review or action is roughly the same as the previous state-based program.”

The ARCI went so far as to say that, “the equine fatality rate remains small and results are mixed as to whether HISA has had any effect, either way.”

“HISA has just been made aware of the Association of Racing Commissioner International (ARCI) report released publicly today,” said a HISA spokesperson. “The report is riddled with factual inaccuracies and mischaracterizations as evidenced by data and information that is publicly available on the HIWU website. HISA remains focused on enforcing and improving upon its Racetrack Safety and Anti-Doping and Medication Control Programs to advance safety and integrity in the sport.”

ARCI said that the prepared the report in anticipation of being asked for it by state racing commissions. They also said that “HISA receives considerable help from State Racing Commissions who are expected to provide almost $18 million in funding or services in the coming year, and that “HISA's almost $81 million proposed budget for next year relies on the thoroughbred racing industry paying almost $60 million in assessments.”

The post ARCI Questions HISA’s Effectiveness in New Report; HISA Claims Report `Factually Inaccurate’ appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights